UNIverse - Public Research Portal

Targeting sialoglycan-mediated immune suppression for cancer therapy

Research Project
|
01.04.2023
- 31.03.2026

No Description available

Funding

Targeting sialoglycan-mediated immune suppression for cancer therapy

SNF Projekt (GrantsTool), 04.2023-03.2026 (36)

PI : Läubli, Heinz.

Members (1)

Heinz Läubli

Principal Investigator

Research Groups

Cellular Immunotherapy (Läubli)

Läubli Lab